Literature DB >> 20665200

Lipid A receptor TLR4-mediated signaling pathways.

Masahiro Yamamoto1, Shizuo Akira.   

Abstract

Lipid A is a strong activator of monocytes to release immune stimulators such as proinflammatory cytokines. Overproduction of inflammatory cytokines such as TNF and IL-6 is known to cause septic shock that frequently leads to multiple organ failure and finally to death. In recent years, Lipid A has also been recognized by a Toll-like receptor, TLR4. Activation of TLR4by LPS or Lipid A triggers signal transduction via the cytoplasmic domain called the Toll/IL-1 Receptor (TIR) domain. Intracellular TIR domain-containing adaptor molecules are involved in the TLR4-mediated signaling pathways. Moreover, a subset of LPS-inducible genes is regulated in two steps by the inducible nuclear protein. Additionally, the TLR4-mediated activation of signaling cascadesis elaborately down-regulated by a number of negative regulators. In this chapter, we discuss the mechanisms of the activation or de-activation program mediated by the Lipid A receptor TLR4.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20665200     DOI: 10.1007/978-1-4419-1603-7_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  27 in total

1.  NMR studies of hexaacylated endotoxin bound to wild-type and F126A mutant MD-2 and MD-2·TLR4 ectodomain complexes.

Authors:  Liping Yu; Rachel L Phillips; DeSheng Zhang; Athmane Teghanemt; Jerrold P Weiss; Theresa L Gioannini
Journal:  J Biol Chem       Date:  2012-03-20       Impact factor: 5.157

2.  Animal models of ricin toxicosis.

Authors:  Chad J Roy; Kejing Song; Satheesh K Sivasubramani; Donald J Gardner; Seth H Pincus
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

Review 3.  Differential Paradigms in Animal Models of Sepsis.

Authors:  S Manoj Kumar Kingsley; B Vishnu Bhat
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

Review 4.  Shiga toxin pathogenesis: kidney complications and renal failure.

Authors:  Tom G Obrig; Diana Karpman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

5.  Astaxanthin prevents against lipopolysaccharide-induced acute lung injury and sepsis via inhibiting activation of MAPK/NF-κB.

Authors:  Xueding Cai; Yanfan Chen; Xiaona Xie; Dan Yao; Cheng Ding; Mayun Chen
Journal:  Am J Transl Res       Date:  2019-03-15       Impact factor: 4.060

Review 6.  Microbiome and chronic inflammatory bowel diseases.

Authors:  Jan Wehkamp; Julia-Stefanie Frick
Journal:  J Mol Med (Berl)       Date:  2016-12-17       Impact factor: 4.599

7.  Modulating the innate immune response by combinatorial engineering of endotoxin.

Authors:  Brittany D Needham; Sean M Carroll; David K Giles; George Georgiou; Marvin Whiteley; M Stephen Trent
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-07       Impact factor: 11.205

8.  Natural killer T cells are required for lipopolysaccharide-mediated enhancement of atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Yasuhiro Andoh; Hisako Ogura; Masashi Satoh; Kentaro Shimano; Hironori Okuno; Satoshi Fujii; Naoki Ishimori; Koji Eshima; Hidekazu Tamauchi; Tatsuro Otani; Yukihito Nakai; Luc Van Kaer; Hiroyuki Tsutsui; Kazunori Onoé; Kazuya Iwabuchi
Journal:  Immunobiology       Date:  2012-07-27       Impact factor: 3.144

Review 9.  Pushing the envelope: LPS modifications and their consequences.

Authors:  Brent W Simpson; M Stephen Trent
Journal:  Nat Rev Microbiol       Date:  2019-07       Impact factor: 60.633

10.  AP-1/IRF-3 Targeted Anti-Inflammatory Activity of Andrographolide Isolated from Andrographis paniculata.

Authors:  Ting Shen; Woo Seok Yang; Young-Su Yi; Gi-Ho Sung; Man Hee Rhee; Haryoung Poo; Mi-Yeon Kim; Kyung-Woon Kim; Jong Heon Kim; Jae Youl Cho
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-06       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.